Datasea, a Nevada-based technology enterprise specialising in advanced acoustic high-tech products and AI multimodal digital solutions, today announced a milestone breakthrough in its acoustic technology. The Company has successfully achieved an exciting leap forward in its acoustic core technologies with the integration of sound wave coupling with AI; the first application for this innovative technology will be precision health management and clinical intervention.

Due to the rapidly growing demand for non-pharmaceutical precision health solutions and increasing policy support for healthcare, the Company is well-positioned to address a market opportunity projected by research and consulting firm Grand View Research at approximately  $100 billion in China and nearly $90 billion globally by 2030.

Leveraging its proprietary sound wave coupling technologies, Datasea has realised precise regulation of the nervous system—including intracranial, peripheral, and cardiac areas—as well as targeted foot acupoint stimulation. This has enabled the creation of a closed-loop ecosystem of detection–analysis–diagnosis–real-time intervention in core medical and health scenarios, with expected high clinical value.

By advancing the convergence of "Acoustics + Neurology," Datasea has positioned ultrasound neuromodulation as its core product strategy. The Company has already developed innovative hardware products and solutions with medical-grade precision, achieved staged results, and commenced the initial phase of commercialisation. These efforts not only open immediate revenue channels but also lay the foundation for deep engagement in the trillion-dollar healthcare ecosystem.